BIOTRANSFORMATION OF HYDRAZINE DERVATIVES IN THE MECHANISM OF TOXICITY

Area of Science:

• Environmental Science
• Toxicology
• Medicinal Chemistry

Background:

• Hydrazine derivatives are utilized in pharmaceuticals for treating tuberculosis and cancer.
• These compounds are also recognized as environmental and food pollutants.
• Hydrazines present significant health risks, including mutagenic and carcinogenic properties.

Purpose of the Study:

• To review the metabolic pathways of hydrazine derivatives.
• To elucidate the formation of reactive species from hydrazines.
• To understand the link between biotransformation, cellular dysfunction, and the effects of hydrazines.

Main Methods:

• Review of existing literature on hydrazine metabolism.
• Analysis of enzymatic and non-enzymatic biotransformation pathways.
• Examination of mechanisms leading to reactive species formation and macromolecular binding.

Main Results:

• Hydrazine biotransformation generates reactive species.
• These reactive species bind to cellular macromolecules, causing dysfunction.
• Metabolic pathways are crucial for both the therapeutic and toxic effects of hydrazines.

Conclusions:

• The metabolism of hydrazine derivatives is key to their pharmacological and pathophysiological actions.
• Understanding these pathways is vital for managing the risks associated with hydrazine exposure.
• Further research into hydrazine biotransformation can inform safer therapeutic strategies.